Microbial levan is an important biopolymer with considerable potential in food and medical applications. Bacillus amyloliquefaciens NK-ΔLP strain can produce high-purity, low-molecularweight levan, but production is relatively low. To enhance the production of levan, six extracellular protease genes (bpr, epr, mpr, vpr, nprE and aprE), together with the tasA gene (encoding the major biofilm matrix protein TasA) and the pgsBCA cluster (responsible for poly-γ-glutamic acid (γ-PGA) synthesis), were intentionally knocked out in the Bacillus amyloliquefaciens NK-1 strain. The highest levan production (31.1 g/L) was obtained from the NK-Q-7 strain (ΔtasA, Δbpr, Δepr, Δmpr, Δvpr, ΔnprE, ΔaprE and ΔpgsBCA), which was 103% higher than that of the NK-ΔLP strain (ΔpgsBCA) (15.3 g/L). Furthermore, the NK-Q-7 strain also showed a 94.1% increase in α-amylase production compared with NK-ΔLP strain, suggesting a positive effect of extracellular protease genes deficient on the production of endogenously secreted proteins. This is the first report of the improvement of levan production in microbes deficient in extracellular proteases and TasA, and the NK-Q-7 strain exhibits outstanding characteristics for extracellular protein production or extracellular protein related product synthesis.Microbial levan, one of the two main types of fructan biopolymers, is mainly polymerized via β -(2 → 6) bonds 1 and has been isolated from Gram-negative bacteria, Gram-positive bacteria and some fungi 2 . Levan has many favourable properties, and is used in variety of industrial applications including in foods, cosmetics and pharmaceuticals [3][4][5] .Previous work has revealed that microbial levan is synthesized in the medium by the secreted levansucrase (EC: 2.4.1.10) from the sucrose substrate 6 . Microorganisms synthesize higher-molecular-weight levan at the beginning of fermentation, after which the molecule is hydrolyzed to lower-molecular-weight levan products in the presence of the β -2,6-fructofuranoside linkage-hydrolyzing enzyme, levanase 5 .Bacillus amyloliquefaciens NK-1 has the ability to co-produce γ -PGA and levan during fermentation. The pgsBCA genes (responsible for γ -PGA synthesis) deletion strain B. amyloliquefaciens NK-Δ LP can produce high-purity levan, with the highest titer observed being 14 g/L 7 . The molecular weight of levan obtained from the NK-Δ LP strain is around 5 kDa, which is much lower than other reported levan products 8 . The Bacillus amyloliquefaciens strain was isolated from fermented food 9 , thus its levan product was supposed to have the potential to be the dietary supplements 10 . However, the low levan production by this strain is unable to meet industrial demands. Therefore, further strain improvement through metabolic engineering is required.